QT
LGND icon

Quantamental Technologies’s Ligand Pharmaceuticals LGND Stock Holding History

Quantamental Technologies’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,381
Closed -$261K – 190
2020
Q3 		$261K Buy
+4,381
New +$299K 0.19% 179
2020
Q1 		– Sell
-3,724
Closed -$242K – 275
2019
Q4 		$242K Buy
+3,724
New +$249K 0.12% 313
2019
Q3 		– Sell
-715
Closed -$51K – 1683
2019
Q2 		$51K Buy
+715
New +$52.7K 0.02% 887
2019
Q1 		– Sell
-803
Closed -$68K – 1652
2018
Q4 		$68K Buy
+803
New +$85.6K 0.04% 686

Other funds holding LGND

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Quantamental Technologies's LGND Position: Q4 2020 in Review

Quantamental Technologies sold out of Ligand Pharmaceuticals (LGND) in Q4 2020, closing a stake of 4,381 shares — an estimated $261K sold.

Quantamental Technologies first reported a position in LGND in Q4 2018 and held it in 4 quarters. The position peaked at $261K in Q3 2020. 242 funds tracked by Wall St. Rank hold LGND as of Q4 2020.

  • Quantamental Technologies reported no remaining Ligand Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Quantamental Technologies sold 4,381 Ligand Pharmaceuticals shares in Q4 2020, an estimated $261K.
  • Quantamental Technologies first reported a position in Ligand Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Quantamental Technologies's Ligand Pharmaceuticals position peaked at $261K in Q3 2020.
  • 242 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2020.

Based on Quantamental Technologies's 13F filing for Q4 2020, filed 16 Feb 2021.